August 08, 2014Article
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho, Kathryn M. Connor, Ying Zhang, Eric Pearlman, Janelle Koppenhaver, Xiaoyin Fan, Christopher Lines, Lars Edvinsson, Peter J. Goadsby, David Michelson
First published August 8, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000771
Tony W. Ho
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Kathryn M. Connor
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Ying Zhang
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Eric Pearlman
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Janelle Koppenhaver
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Xiaoyin Fan
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Christopher Lines
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Lars Edvinsson
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Peter J. Goadsby
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
David Michelson
From Merck & Co., Inc. (T.W.H., K.M.C., Y.Z., J.K., X.F., C.L., D.M.), Whitehouse Station, NJ; Mercer University School of Medicine (E.P.), Savannah, GA; Department of Medicine (L.E.), Institute of Clinical Sciences, Lund University and Lund University Hospital, Sweden; Headache Group (P.J.G.), NHIR–Wellcome Trust Clinical Research Facility, King's College London, UK; and Department of Neurology (P.J.G.), University of California, San Francisco. T.W.H. is currently affiliated with AstraZeneca Pharmaceuticals LP, Wilmington, DE. X.F. is currently affiliated with Elan Corporation, Boston, MA.
Chinese Translation
Neurology® data supplements are not copyedited before publication. Published editorials
and translations have been copyedited.
© 2017 American Academy of Neurology.
Files in this Data Supplement:
- Chinese Translation - PDF